Skip to navigation Skip to content



In this article


COViMS (COVID-19 Infections in MS & Related Diseases) is a joint effort of the National MS Society and the Consortium of MS Centers to capture information on outcomes of people with MS and other CNS demyelinating diseases (Neuromyelitis Optica, or MOG antibody disease) who have developed COVID-19.  
If you have a patient who has highly suspicious or laboratory confirmed COVID19, we ask that you enter those cases into the database.  As the purpose is outcomes of COVID19, Please report only after a minimum of 7 days and sufficient time has passed to observe the disease course through resolution of acute illness or death. View current data.

Enter a case

Enter a case


The National MS Society is partnering with the iConquerMS Patient-Powered Research Network to gather data on how well the COVID-19 vaccine is tolerated in the MS population. COVER-MS a study that assesses the experiences of those diagnosed with MS who received the COVID-19 vaccines. People with MS who have received the vaccine can visit the iConquerMS website to share their experience.

Learn more

Learn more


We are closely watching the COVID-19 situation and taking action as we all move through this uncharted territory. We know that the best information for someone living with MS about their unique situation comes from their healthcare providers, and we refer them to you first whenever possible. But we also know that due to the unique circumstances around COVID-19, that may be more difficult.

We are here to partner with you to provide your patients with a trustworthy platform of fact-based information about COVID19 and multiple sclerosis, including information on the COVID-19 vaccine. The MS Navigator® program is an excellent resource for MS-specific support and information nationwide.

Follow us on Twitter for the latest COVID-19 updates.  Twitter @mssocietyhcp

COVID-19 Vaccines

MS and COVID-19: A Webinar Series for Healthcare Providers

Upcoming Events

There are currently no upcoming events. Check back regularly for scheduled programs.


March 3, 2021 - The National MS Society and the Consortium of MS Centers led a discussion of COVID-19 vaccines and MS. We reviewed vaccine safety, efficacy and considerations for timing the vaccine with certain disease modifying therapies. 

Speakers: Nancy Sicotte, MD, Chair of the National MS Society’s National Medical Advisory Committee, Cedars-Sinai Medical Center
Scott Newsome, DO, President of the Board of Governors of the Consortium of MS Centers, Johns Hopkins University
Moderator: Rachael Stacom, ANP-BC, Independence Care System

View the recording

View the vaccine guidance

Clinical Practice Resources

Resources for Patients



© 2020 The National Multiple Sclerosis Society is a tax exempt 501(c)3 nonprofit organization. Its Identification Number (EIN) is 13-5661935.